Navigating Regulatory Changes in GCC Pharmaceutical Markets
Navigating Regulatory Changes in GCC Pharmaceutical Markets The Gulf Cooperation Council (GCC) has stepped up reforms that affect how pharma companies register, serialize, price, and trace products across Saudi Arabia, UAE, Qatar, Bahrain, Oman, and Kuwait. Below is a practical, country-by-country field guide with the key shifts to watch—and how to stay compliant while keeping […]
Digital Transformation in Pharmaceutical Distribution
Digital Transformation in Pharmaceutical Distribution Pharmaceutical distribution is being reshaped by specialty therapies, tighter track-and-trace rules, and the expectation that data should move as reliably as medicines. Here’s a practical guide to the technologies, operating changes, and KPIs that matter now—plus a staged roadmap to move from pilots to enterprise scale. Why transform now Regulatory […]
Market Access Strategies for MENA Region Success
Market Access Strategies for MENA Region Success Winning market access across the Middle East & North Africa (MENA) means aligning (1) regulatory pathways, (2) pricing & tenders, (3) local stakeholder value, and (4) supply reliability—country by country. Below is a practical playbook with high-value moves and concrete references you can rely on. 1) Build your […]